News
A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but ...
Clinical Trials Arena on MSN22h
Stuart reports initial outcomes from trial of ophthalmic solution for DEDStuart Therapeutics has reported initial findings from its 29-day randomised Phase III trial of the ST-100 (vezocolmitide) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback